We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SK bioscience

News List

Novavax and SK bioscience Expand Manufacturing Agreement prnasia
December 24, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience...
SK bioscience’s COVID-19 vaccine plant in South Korea gets European nod expresspharma
May 18, 2021
The certification approves the production and processing line and quality system of SK bioscience’s Andong plant, which produces COVID-19 vaccines developed by AstraZeneca Plc and Novavax Inc.
Novavax, SK Bioscience Expand Vax Pact contractpharma
February 18, 2021
The existing partnership for manufacture of NVX-CoV2373 has been expanded to increase production capacity and supply vaccines to the Korean Government.
Novavax announces collaboration with SK bioscience for COVID-19 vaccine expresspharma
August 14, 2020
SK bioscience will manufacture the vaccine antigen component for use in the final drug product globally during the pandemic period.